{"title":"Impact of Surveillance Colonoscopy Timing on Colorectal Cancer Incidence Following Advanced Adenoma Resection.","authors":"Munenori Honda, Yasushi Oda, Ryosuke Gushima, Hideaki Miyamoto, Hideaki Naoe, Kiwamu Hasuda, Kouichi Sakurai, Yoshitaka Murakami, Yasuhito Tanaka","doi":"10.14309/ajg.0000000000003390","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Index colonoscopy findings can affect surveillance decisions that have an impact on the future risk of colorectal cancer (CRC). However, the effectiveness of surveillance colonoscopy in reducing CRC risk remains unclear. This study aimed to evaluate whether the timing of the first surveillance colonoscopy affected CRC incidence rates.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study at two community endoscopy clinics between 2005 and 2021, including 20,397 individuals. Based on the findings at index colonoscopy, we categorized into four groups: advanced adenoma (AA), ≥3 non-AAs, 1-2 non-AAs, and no adenoma. We compared the cumulative incidence of CRC among these groups, focusing on whether the first surveillance interval was less than or greater than 3 years after index colonoscopy.</p><p><strong>Results: </strong>Index colonoscopy findings identified 11,601 subjects with no adenoma, 5,288 with 1-2 non-AA, 1,484 with ≥3 non-AA, and 2,024 with AA. There were 50 cases of CRC: 23 in the no adenoma, 10 in the 1-2 non-AA, six in the ≥3 non-AA, and 11 in the AA group. First surveillance after 3 years was associated with a higher incidence of subsequent CRC in the AA group (hazard ratio, 3.49; 95% confidence interval, 1.06-11.46; P=0.04).</p><p><strong>Discussion: </strong>In the AA group, surveillance colonoscopy within 3 years was associated with a lower risk of CRC. These findings suggest that a first surveillance within 3 years is particularly effective in patients with AA.</p>","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":8.0000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14309/ajg.0000000000003390","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Index colonoscopy findings can affect surveillance decisions that have an impact on the future risk of colorectal cancer (CRC). However, the effectiveness of surveillance colonoscopy in reducing CRC risk remains unclear. This study aimed to evaluate whether the timing of the first surveillance colonoscopy affected CRC incidence rates.
Methods: We conducted a retrospective cohort study at two community endoscopy clinics between 2005 and 2021, including 20,397 individuals. Based on the findings at index colonoscopy, we categorized into four groups: advanced adenoma (AA), ≥3 non-AAs, 1-2 non-AAs, and no adenoma. We compared the cumulative incidence of CRC among these groups, focusing on whether the first surveillance interval was less than or greater than 3 years after index colonoscopy.
Results: Index colonoscopy findings identified 11,601 subjects with no adenoma, 5,288 with 1-2 non-AA, 1,484 with ≥3 non-AA, and 2,024 with AA. There were 50 cases of CRC: 23 in the no adenoma, 10 in the 1-2 non-AA, six in the ≥3 non-AA, and 11 in the AA group. First surveillance after 3 years was associated with a higher incidence of subsequent CRC in the AA group (hazard ratio, 3.49; 95% confidence interval, 1.06-11.46; P=0.04).
Discussion: In the AA group, surveillance colonoscopy within 3 years was associated with a lower risk of CRC. These findings suggest that a first surveillance within 3 years is particularly effective in patients with AA.
期刊介绍:
Published on behalf of the American College of Gastroenterology (ACG), The American Journal of Gastroenterology (AJG) stands as the foremost clinical journal in the fields of gastroenterology and hepatology. AJG offers practical and professional support to clinicians addressing the most prevalent gastroenterological disorders in patients.